Parenteral Nutrition Bags Market Size & Share 2024 - 2032

Parenteral Nutrition Bags Market Size

Parenteral Nutrition Bags Market size was valued at USD 749.6 million in 2023 and is expected to grow at a CAGR of 6.8% between 2024 and 2032, driven by increasing prevalence of chronic diseases such as cancer, gastrointestinal disorders, and malnutrition, which require parenteral nutrition for patients unable to receive adequate nutrition orally. This drives the demand for parenteral nutrition products, in turn fuelling the demand for parenteral nutrition bags.

Additionally, the rising geriatric population, who are more prone to such diseases and malnutrition, is further contributing to the rising demand of parenteral nutrition solutions. Moreover, technological advancements in the design and materials used in these bags are also contributing to market expansion, as they improve the safety and efficacy of parenteral nutrition delivery. Furthermore, the growing awareness among healthcare professionals about the benefits of parenteral nutrition in patient care is driving the adoption of these products, further boosting the overall market size.
 

Parenteral nutrition bags are sterile, specialized containers used to deliver a balanced mix of nutrients, including carbohydrates, proteins, fats, vitamins, and minerals, directly into a patient's bloodstream. These bags are designed to be compatible with intravenous (IV) administration systems and are typically made from a durable, flexible material that can withstand the pressures associated with IV infusion.

Parenteral Nutrition Bags Market Trends

• The increasing prevalence of metabolic & chronic disorders and malnutrition drives the demand for parenteral nutrition solutions across the globe, thus stimulating the demand for parenteral nutrition bags.
   
• For instance, the State of Food Security and Nutrition in the World 2023 report revealed that approximately 2.4 billion individuals lacked consistent access to nutritious food in 2022, with child malnutrition rates remaining alarmingly high.
   
• Metabolic disorders such as diabetes, hyperlipidemia, and malnutrition often require specialized clinical nutrition support, which can be provided through parenteral nutrition bags.
   
• These bags offer a convenient and efficient way to deliver essential nutrients and medications to patients who cannot consume food orally or through enteral feeding, making them a crucial component in managing these conditions.
   
• Thus, as the prevalence of metabolic disorders, malnutrition, and other chronic diseases continues to rise globally, the demand for parenteral nutrition bags is expected to increase, thereby fueling market growth.
   

Parenteral Nutrition Bags Market Analysis

Based on type, the global market is segmented into single-chamber bags, dual-chamber bags, and multi-chambered bags. The single-chamber bags segment dominated the market with revenue of USD 400.4 million in 2023.
 

• Single chamber bags have gained a significant market share in the parenteral nutrition market due to their convenience, ease of use, and compatibility with various formulations.
   
• The single chamber design reduces the risk of contamination and ensures accurate dosing, making them a preferred choice for healthcare facilities. Additionally, the compact size of these bags makes storage and transportation more efficient, further contributing to their popularity.
   
• Overall, the convenience, safety, and efficiency offered by single chamber bags have made them a preferred choice in the parenteral nutrition market, driving their high market share.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on material, the global parenteral nutrition bags market is segmented into polyvinyl chloride (PVC), ethylene vinyl acetate (EVA), polypropylene (PP), and other materials. The polyvinyl chloride (PVC) segment held a dominant market share of 35.3% in 2023.
 

• High market share of polyvinyl chloride (PVC) segment can be attributed to its advantageous properties and cost-effectiveness. Its flexibility, durability, and compatibility with a variety of medications make it a preferred choice for packaging and delivering parenteral nutrition solutions.
   
• Additionally, PVC offers excellent barrier properties, protecting the contents from contamination and ensuring product integrity.
   
• Furthermore, the material's transparency allows for easy monitoring of the solution's color and clarity, which is essential for ensuring the quality and safety of the product. All these factors together contribute to the segment’s dominance in the market.
   

Based on capacity, the global parenteral nutrition bags market is classified into 50 - 150 ml, 150 - 500 ml, 500 – 1,500 ml, 1,500 – 3,500 ml, and other capacities. The 150 - 500 ml segment is expected to reach USD 452 million by 2032.
 

• The 150 - 500 ml bags segment holds a significant share in the parenteral nutrition bags market due to its versatility and widespread usage in various healthcare settings.
   
• These bags are preferred for their moderate volume capacity, making them suitable for a wide range of patient needs, including those requiring short-term or moderate nutritional support.
   
• Their popularity is also attributed to their compatibility with different types of parenteral nutrition solutions, including those containing proteins, lipids, and carbohydrates, enhancing their utility across diverse patient populations.
   
• Additionally, the compact size of these bags makes them convenient for storage, transportation, and administration, further contributing to their high market share in the market.
   

Based on end-use, the parenteral nutrition bags market is classified into pharmaceutical companies, hospitals, and pharmacies & compounding service providers. The pharmaceutical company’s segment is expected to grow at a CAGR of 7.1% between 2024 - 2032.
 

• Pharmaceutical companies are major producers of parenteral nutrition due to their expertise in developing and manufacturing specialized nutrition solutions, this makes them prominent end-users in the parenteral nutrition bags market.
   
• These companies invest heavily in research and development to create innovative formulations that meet the diverse nutritional needs of patients. Additionally, pharmaceutical companies have a strong distribution network, enabling them to reach healthcare facilities worldwide.
   
• Their focus on quality control and regulatory compliance further enhances their position in the market, making them key end-users of parenteral nutrition bags.
   

In 2023, Asia Pacific region held a market share of 31.7% in the global parenteral nutrition bags market and is expected to reach USD 436.4 million by 2032.
 

• The region's large and aging population, coupled with increasing incidences of chronic diseases and a growing awareness of the importance of nutrition, has fueled demand for parenteral nutrition products, thereby driving the parenteral nutrition bags market.
   
• Additionally, improving healthcare infrastructure and rising healthcare expenditure in countries like China, India, and Japan have further boosted market growth.
   
• The Asia Pacific region also benefits from the presence of key market players focusing on expanding their operations in this lucrative market, thereby driving competition and innovation.
   

Parenteral Nutrition Bags Market Share

The global market is characterized by the presence of established players offering a wide range of products. Key players compete on factors such as product efficacy, safety profile, pricing, materials used, distribution networks, and brand reputation. Continuous focus on innovation, strategic partnerships, and mergers and acquisitions are common strategies employed to gain a competitive edge in this market.
 

Parenteral Nutrition Bags Market Companies

Prominent players operating in the global parenteral nutrition bags market are as mentioned below:

• AdvaCare Pharma
• Baxter International Inc.
• B. Braun Medical Inc.
• Diffuplast S.r.l.
• Grifols SA
• GVS S.p.A. 
• HEMEDIS GmbH
• INFRA S.r.l.
• Technoflex
• Valmed s.r.l
   

Parenteral Nutrition Bags Industry News:

• In May 2022, GVS acquired 100% of the share capital of the Italian Group Haemotronic, a company specializing in the production of components and bags for the medical sector with plants in Italy and Mexico. This acquisition contributes to the growth of GVS's product portfolio, allowing for the integration and expansion of products offered and strengthening its presence in the European and North American healthcare markets.
   
• In August 2019, Baxter launched its product Finomel, a ready-to-use triple-chamber bag for parenteral nutrition (PN) in Europe. Finomel expands the company’s portfolio of leading premixed PN formulations and offers healthcare providers with additional options to meet adult patients’ diverse nutritional needs.
   

The parenteral nutrition bags market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 - 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Single-chamber bags
• Dual-chamber bags
• Multi-chambered bags

Market, By Material

• Polyvinyl chloride (PVC)
• Ethylene vinyl acetate (EVA)
• Polypropylene (PP)
• Other materials

Market, By Capacity

• 50 - 150 ml
• 150 - 500 ml
• 500 – 1,500 ml
• 1,500 – 3,500 ml
• Other capacities

Market, By End-use

• Pharmaceutical companies
• Hospitals
• Pharmacies & compounding service providers

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • Rest of Middle East and Africa